001     305536
005     20251028115603.0
024 7 _ |a 10.1002/ueg2.70133
|2 doi
024 7 _ |a pmid:41137746
|2 pmid
024 7 _ |a 2050-6406
|2 ISSN
024 7 _ |a 2050-6414
|2 ISSN
037 _ _ |a DKFZ-2025-02210
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Vornhülz, Marlies
|0 0000-0003-1197-0419
|b 0
245 _ _ |a Common Practice of Percutaneous Drainage in Necrotising Pancreatitis-A Multicentre Retrospective Study (DRACULA).
260 _ _ |a Hoboken, NJ
|c 2025
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1761574209_3448747
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
520 _ _ |a Acute necrotising pancreatitis carries high mortality, especially if infected necrosis occurs. While percutaneous drainage may be required when internal drainage is not feasible, reliable guidelines for managing percutaneous drains are lacking. This study aimed to assess the common practice of percutaneous drainage therapy for infected pancreatic necrosis.This retrospective study among 29 tertiary care centres included all patients hospitalised for necrotising acute pancreatitis from 01/2016 until 12/2022 with at least one percutaneous drain. The length of hospital stay was the primary endpoint, with mortality as the secondary endpoint. Between-group comparisons were conducted using the ratio of restricted mean survival time (RMST) after adjusting for confounders.585 patients (67% male) from 29 tertiary care centres in 15 countries in Europe, Canada and Bolivia were included in the analysis. Length of hospitalisation or mortality did not differ between the flushed (n = 398) and non-flushed groups (RMST ratio 1.04, p-value = 0.42 and RMST ratio 1.05, p-value = 0.1 respectively). Mortality was significantly lower in those patients who received a combination of percutaneous and internal drains (dual-modality drainage, n = 243) as compared to those who received percutaneous drains only (RMST ratio 1.05, p-value = 0.01). Flushing with antibiotics as compared to saline was not associated with shorter length of hospital stay or lower mortality (RMST ratio 0.98, p-value = 0.78 and 0.97, p-value = 0.48 respectively).This study reveals notable differences in therapeutic concepts and flushing management for percutaneous drains. While flushing itself was not associated with a shorter length of hospitalisation or lower in-hospital mortality, a lower mortality was observed when internal and percutaneous drainage were used in combination.The study was prospectively registered in the German Clinical Trials Register (Deutsches Register Klinischer Studien, DRKS) under the registration number DRKS00032231.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a drainage
|2 Other
650 _ 7 |a flushing
|2 Other
650 _ 7 |a necrosis
|2 Other
650 _ 7 |a pancreatitis
|2 Other
700 1 _ |a Sirtl, Simon
|0 0000-0002-6047-334X
|b 1
700 1 _ |a Xu, Yujun
|0 0000-0002-8487-7584
|b 2
700 1 _ |a Klauss, Sarah
|0 0000-0003-3002-7848
|b 3
700 1 _ |a Orgler-Gasche, Elisabeth
|0 0000-0003-1904-2553
|b 4
700 1 _ |a Bezmarevic, Mihailo
|0 0000-0003-1938-8298
|b 5
700 1 _ |a Jovanovic, Milan
|b 6
700 1 _ |a Ricci, Claudio
|0 0000-0002-6638-4479
|b 7
700 1 _ |a Fernandez Y Viesca, Michael
|b 8
700 1 _ |a Arvanitakis, Marianna
|b 9
700 1 _ |a Hadi, Amer
|0 0000-0002-9481-6021
|b 10
700 1 _ |a Prahm, August Pilegaard
|0 0000-0002-3359-6061
|b 11
700 1 _ |a Di Mauro, Davide
|0 0000-0003-2348-5664
|b 12
700 1 _ |a Ruess, Dietrich A
|0 0000-0003-4371-2246
|b 13
700 1 _ |a Focke, Carola
|0 0009-0007-4024-0358
|b 14
700 1 _ |a Bender, Fabienne
|b 15
700 1 _ |a Hamm, Jacob
|0 0000-0003-4960-6858
|b 16
700 1 _ |a Ammer-Herrmenau, Christoph
|0 0009-0009-2465-8927
|b 17
700 1 _ |a Gonçalves, Tiago Cúrdia
|0 0000-0001-5540-6452
|b 18
700 1 _ |a Gonçalves, João Carlos
|0 0000-0002-4081-8072
|b 19
700 1 _ |a Calavrezos, Lenika
|0 0009-0007-8279-1799
|b 20
700 1 _ |a Götz, Mara
|0 0000-0003-4368-2016
|b 21
700 1 _ |a Stoerzer, Simon
|b 22
700 1 _ |a Schmelzle, Moritz
|b 23
700 1 _ |a Nawacki, Łukasz
|b 24
700 1 _ |a Condori, Carlos
|b 25
700 1 _ |a Seitzinger, Max
|b 26
700 1 _ |a Seelig, Julian
|0 0000-0001-6081-2316
|b 27
700 1 _ |a Chooklin, Serge
|0 0000-0002-3503-8450
|b 28
700 1 _ |a Chuklin, Serhii
|b 29
700 1 _ |a Rasch, Sebastian
|0 0000-0002-7917-8017
|b 30
700 1 _ |a Phillip, Veit
|b 31
700 1 _ |a Pandanaboyana, Sanjay
|0 0000-0003-3099-2197
|b 32
700 1 _ |a Aljaberi, Rami
|b 33
700 1 _ |a Kuzman, Matta
|0 0000-0002-9008-2358
|b 34
700 1 _ |a Meinhardt, Christian
|0 0000-0002-6801-4076
|b 35
700 1 _ |a González de la Higuera Carnicer, Belén
|b 36
700 1 _ |a Ruiz-Clavijo García, David
|b 37
700 1 _ |a Eross, Bálint
|0 0000-0003-3658-8427
|b 38
700 1 _ |a Hegyi, Peter
|0 0000-0003-0399-7259
|b 39
700 1 _ |a Kerbazh, Nizar
|0 0000-0002-7722-9896
|b 40
700 1 _ |a Moga, Tudor Voicu
|b 41
700 1 _ |a Pawlak, Katarzyna
|0 0000-0002-0771-1177
|b 42
700 1 _ |a Calo, Natalia
|b 43
700 1 _ |a Khalaf, Kareem
|0 0000-0002-5534-7533
|b 44
700 1 _ |a Brunner, Maximilian
|b 45
700 1 _ |a Schulte, Lucas
|b 46
700 1 _ |a Kleger, Alexander
|0 0000-0003-0592-5232
|b 47
700 1 _ |a Ruiz Rebollo, María Lourdes
|0 0000-0003-4600-9257
|b 48
700 1 _ |a Seidensticker, Max
|b 49
700 1 _ |a Wildgruber, Moritz
|b 50
700 1 _ |a Mansmann, Ulrich
|0 0000-0002-9955-8906
|b 51
700 1 _ |a Stubbe, Hans
|0 0000-0002-7873-996X
|b 52
700 1 _ |a Mayerle, Julia
|0 0000-0002-3666-6459
|b 53
700 1 _ |a Beyer, Georg
|0 0000-0002-7607-8264
|b 54
700 1 _ |a DRACULA study group: Laszlo Czako, Valentina Ratkajec
|b 55
|e Collaboration Author
773 _ _ |a 10.1002/ueg2.70133
|g p. ueg2.70133
|0 PERI:(DE-600)2728585-6
|p nn
|t United european gastroenterology journal
|v nn
|y 2025
|x 2050-6406
909 C O |o oai:inrepo02.dkfz.de:305536
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 0000-0003-4371-2246
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-13
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-13
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-13
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-13
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b UNITED EUR GASTROENT : 2022
|d 2024-12-13
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b UNITED EUR GASTROENT : 2022
|d 2024-12-13
920 1 _ |0 I:(DE-He78)FR01-20160331
|k FR01
|l DKTK Koordinierungsstelle Freiburg
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)FR01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21